Queen's University
Kingston, Ontario, K7L 2V7, Canada
Location status: Recruiting
NCT Number: NCT06681649
~80% of ICU survivors experience profound long-term cognitive, physical, and psychiatric impairments known as post-intensive care syndrome (PICS). Caregivers additionally experience similar detrimental psychosocial effects following discharge. Despite this knowledge, follow-up care is almost non-existent. ICU follow-up clinics may mitigate these long-term impacts, but lack evaluation of their effectiveness. This trial will evaluate the effectiveness of ICU follow-up clinics vs. standard-of-care in improving qualitative/clinical outcomes of ICU survivors and caregivers, with those receiving follow-up care hypothesized to have improved outcomes.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Kingston, Ontario, K7L 2V7, Canada
Location status: Recruiting
~80% of ICU survivors experience profound long-term cognitive, physical, and psychiatric impairments known as post-intensive care syndrome (PICS), with patients experiencing prolonged delirium or mechanical ventilation having a heightened risk. Caregivers additionally experience similar detrimental psychosocial effects following discharge. Despite this knowledge, follow-up care is almost non-existent. ICU follow-up clinics may mitigate these long-term impacts, but lack evaluation of their effectiveness. This pragmatic, mixed-methods, open-label randomized (1:1) controlled trial will evaluate the effectiveness of ICU follow-up clinics vs. standard-of-care in improving qualitative/clinical outcomes of ICU survivors and caregivers, with those receiving follow-up care hypothesized to have improved outcomes.
The intervention group will receive: 1) specialized follow-up care at 1- and 3-months following discharge, 2) information packages on expectations following discharge, and 3) diaries for the healthcare team, family, and patient to journal their experiences throughout recovery. The control group will receive generalized standard of care through their primary care provider. Focus groups will be used for qualitative assessment to elucidate what patients find most important for their recovery, using a patient-centred approach. Clinical assessments will evaluate neurocognitive function, quality of life, anxiety, depression, post-traumatic stress disorder, and resiliency among both ICU survivors and caregivers; chronic pain, fatigue, activities of daily living, lower extremity strength, polypharmacy, and hospital readmissions among ICU survivors; and caregiver burden and sleep quality among caregivers.
ICU survivorship extends beyond surviving the ICU. This program of research will unravel the aspects of follow-up care needed to mitigate the long-term impacts of PICS and improve patient and caregiver outcomes. This study is a first-step toward achieving this goal, by understanding barriers to successful recruitment, enrolment, data collection, and follow-up in this vulnerable cohort of ICU survivors and caregivers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- ICU survivors
Inclusion criteria
- Caregivers
Exclusion criteria
- ICU survivors and caregivers
The intervention group will receive follow-up care through the specialized post-ICU follow-up clinic at KHSC at approximately 1- and 3-months following ICU discharge. Caregivers will also be invited to participate in the follow-up clinic along with the ICU survivor participant.
In addition to receiving specialized follow-up clinical care, ICU survivor participants and their caregivers will also receive the following additional items as part of a bundled care intervention program (see Appendix):
Time frame: 6 months
To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measure:
Consent rate, measured as the proportion of eligible population who consent to participate
Time frame: 6 months
To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures:
Enrolment rate, measured as the proportion of consented participants who are randomized
Time frame: 6 months
To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures:
Follow-up rate, measured as the proportion of enrolled participants who complete follow-up visits at 1-, 3-, and 6-months
Time frame: 6 months
To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures:
Data capture rate, measured as the percentage of data elements acquired at each study time point
Time frame: 6 months
To determine the feasibility of a pragmatic RCT evaluating the impact of a post-ICU follow-up clinic intervention on clinical and qualitative patient and caregiver outcomes, as assessed via the following measures:
Rate of adverse events, assessed using the number of hospital and ICU readmissions, as well as the number of visits to the emergency department at 6 months.
Time frame: 6 months
To determine the qualitative impact of a post-ICU follow-up care intervention on patients and caregivers, as assessed via qualitative analysis of focus group discussions.
Time frame: 6 months
To perform a process evaluation of the multimodal ICU follow-up bundle of care intervention to understand the implementation, acceptability, content, barriers, and facilitators to use of diaries, informational materials, and the follow-up clinic.
Time frame: 6 months
Neurocognitive outcomes, as measured using the MoCA
Time frame: 6 months
To determine the effect of a post-ICU follow-up clinic intervention on changes in weight and body-mass index (BMI) following ICU discharge
Time frame: 6 months
Frailty, as measured using the CFS
Time frame: 6 months
Quality of life outcomes, as measured using the SF-36
Time frame: 6 months
Anxiety and depression, as measured using the HADS
Time frame: 6 months
PTSD, as measured using the PTSS-14
Time frame: 6 months
Chronic pain, as measured using the Chronic Pain Grade Scale (CPGS)
Time frame: 6 months
Chronic fatigue, as measured using the Fatigue Severity Scale (FSS)
Time frame: 6 months
Activities of daily living (ADLs), as measured using the Katz Index of ADLs
Time frame: 6 months
Instrumental ADLs, as measured using the Lawton IADL score
Time frame: 6 months
Lower extremity strength, as measured using the 30-second Sit-to-Stand Test
Time frame: 6 months
Dyadic resiliency among ICU survivors and caregivers, as measured using the dyadic Connor-Davidson 10-item Resiliency Scale (CD-RISC-10)
Time frame: 6 months
To determine the effect of a post-ICU follow-up clinic intervention on return to work by ICU survivors
Time frame: 6 months
Employment status relative to previous among caregivers
Contact information is provided by the study sponsor or research team.
J G Boyd, MD PhD
CONTACT
6135496666 x6228 ext. 6228
Natasha A Jawa, MSc
CONTACT
Queen's University
Other
Improving Medical and Psychological Outcomes After Discharge - Feasibility Study for a Pragmatic, Mixed-methods, Open-label Randomized Controlled Trial Examining the Effectiveness of a Follow-up Clinic for ICU Survivors and Caregivers
Acronym: IMPACT-ICU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04989790
Child, Confusion
Madera, California, United States
View Trial DetailsNCT06019078
Agnosia, Analgesia
Abbotsford British Columbia, British Columbia, Canada
View Trial DetailsNCT05999903
Confusion, Critical Illness
Temple, Texas, United States
View Trial DetailsNCT07694206
Critical Illness, Delirium in the Intensive Care Unit
La Jolla, California, United States
View Trial Details